|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.030 HKD | -0.96% |
|
+0.98% | +28.75% |
| 06-26 | Fusen Pharma Gets Marketing Nod for Influenza Drug in China | MT |
| 06-18 | Fusen Pharma Unit to Raise 300 Million Yuan From State-Owned Investors | MT |
| Market Cap | 658M 761M 97.13M 84.88M 78.32M 72.19M 136M 9.35B 139M 936M 368M 4.58B 365M 357M 15.77B | P/E 2024 |
-2.95x | P/E 2025 | -45.1x |
|---|---|---|---|---|---|
| Enterprise Value | 880M 1.02B 130M 113M 105M 96.54M 182M 12.51B 186M 1.25B 492M 6.13B 488M 477M 21.09B | EV / Sales 2024 |
2.83x | EV / Sales 2025 | 2.76x |
| Free-Float |
26.11% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | -0.96% | ||
| 1 week | +0.98% | ||
| Current month | -3.74% | ||
| 1 month | +5.10% | ||
| 3 months | -15.57% | ||
| 6 months | +37.33% | ||
| Current year | +28.75% |
| 1 week | 1 |  | 1.08 |
| 1 month | 0.85 | | 1.11 |
| Current year | 0.68 | | 1.44 |
| 1 year | 0.3 | | 1.75 |
| 3 years | 0.24 | | 1.75 |
| 5 years | 0.24 | | 3.48 |
| 10 years | 0.24 | | 20 |
| Manager | Title | Age | Since |
|---|---|---|---|
Zhen Li
DFI | Director of Finance/CFO | 48 | 2019-04-17 |
Zhi Ming Cao
IRC | Investor Relations Contact | 40 | 2013-01-17 |
Yuk Hong Yeung
SEC | Corporate Secretary | 36 | 2024-09-29 |
| Director | Title | Age | Since |
|---|---|---|---|
Kwok Tung Lee
BRD | Director/Board Member | 58 | 2019-04-14 |
Ho Ming Yu
BRD | Director/Board Member | 49 | 2025-09-29 |
Tai Sheng Hou
BRD | Director/Board Member | 63 | 2017-04-06 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 4/19/24 | Other | Chairman | 650,000 | 0.0867% | ||
| 4/18/24 | Other | Chairman | 240,000 | 0.0320% | ||
| 4/18/24 | Other | Chairman | 240,000 | 0.0320% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.96% | +0.98% | +194.29% | -24.26% | 98.08M | |
| -0.90% | -0.15% | +13.46% | +79.34% | 48.56B | |
| -0.23% | -1.65% | +65.14% | +115.81% | 35.65B | |
| -0.76% | -1.44% | -4.30% | +37.38% | 11.98B | |
| -0.88% | -0.62% | +16.38% | +89.65% | 11.95B | |
| +0.19% | +2.87% | +34.92% | +127.54% | 9.29B | |
| -0.75% | -0.91% | +18.26% | +37.23% | 6.95B | |
| -9.93% | +0.35% | -29.90% | +14.89% | 6.81B | |
| +3.37% | -0.10% | +49.31% | -4.38% | 6.79B | |
| -2.25% | -2.08% | +0.40% | +218.27% | 6.7B | |
| Average | -1.31% | +0.57% | +35.80% | +69.15% | 14.48B | |
| Weighted average by Cap. | -0.93% | +0.24% | +25.72% | +86.17% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 326M 377M 48.1M 42.03M 38.79M 35.75M 67.39M 4.63B 68.88M 464M 182M 2.27B 181M 177M 7.81B | 273M 316M 40.33M 35.24M 32.52M 29.98M 56.5M 3.88B 57.76M 389M 153M 1.9B 151M 148M 6.55B |
| Net income | -189M -218M -27.85M -24.34M -22.46M -20.7M -39.02M -2.68B -39.89M -268M -106M -1.31B -105M -102M -4.52B | -11.78M -13.63M -1.74M -1.52M -1.4M -1.29M -2.44M -167M -2.49M -16.76M -6.59M -82M -6.53M -6.39M -282M |
| Net Debt | 367M 425M 54.18M 47.35M 43.69M 40.27M 75.91M 5.22B 77.59M 522M 205M 2.56B 203M 199M 8.8B | 222M 257M 32.75M 28.62M 26.41M 24.34M 45.88M 3.15B 46.9M 316M 124M 1.54B 123M 120M 5.32B |
Employees
1,005
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-17 | HK$1.030 | -0.96% | 25,000 |
| 26-07-16 | HK$1.040 | +2.97% | 16,000 |
| 26-07-15 | HK$1.010 | -2.88% | 306,000 |
| 26-07-14 | HK$1.040 | 0.00% | 16,000 |
| 26-07-13 | HK$1.040 | +1.96% | 23,000 |
- Stock Market
- Stocks
- 1652 Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
